Vaccine profit boost for AstraZeneca
A SWINE flu vaccine windfall worth $152 million (£92.3m) has contributed to a leap in third-quarter profits at drug giant AstraZeneca.
AstraZeneca yesterday said it saw a 23 per cent hike in profits and 10 per cent rise in sales, helped in part by sales of its H1N1 vaccine as it began shipping doses earlier this month under the US immunisation programme.
On Wednesday, fellow pharmaceutical firm GlaxoSmithKline confirmed expectations for 1 billion in swine flu vaccine sales in the fourth quarter alone.
- David Cameron is playing into the SNP’s hands, says Michael Forsyth
- Teacher dies and 27 injured in coach crash
- Brian Monteith: Positive push to keep Scotland in the union
- Rangers administration: European hopes in doubt as wait goes on for tax tribunal result
- Rangers administration: Calls grow for finance inquiry
- David Cameron is playing into the SNP’s hands, says Michael Forsyth
- Scottish independence: Ruth Davidson points to welfare
- Scottish independence: SNP’s plans ‘in a state of flux’, Willie Rennie claims
- First Minister accused of snubbing devolved nations
- ‘Troubled times’ for shops as customers fall
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Monday 20 February 2012
Today
Light rain
Temperature: 7 C to 9 C
Wind Speed: 25 mph
Wind direction: South west
Tomorrow
Cloudy
Temperature: 9 C to 12 C
Wind Speed: 21 mph
Wind direction: South west

